Associations of hormone replacement therapy and oral contraceptives with risk of colorectal cancer defined by clinicopathological factors, beta-catenin alterations, expression of cyclin D1, p53, and microsatellite-instability
Crossref DOI link: https://doi.org/10.1186/1471-2407-14-371
Published Online: 2014-05-25
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Brändstedt, Jenny
Wangefjord, Sakarias
Nodin, Björn
Eberhard, Jakob
Jirström, Karin
Manjer, Jonas
License valid from 2014-05-25